Companies / Paragon 28

Paragon 28 coverage

13 issues

• Is Transverse Tibial Transport the Next Gold Rush?

  Six companies already have systems. The evidence is promising but unfinished, the wound indication isn't on the label, and scope of practice may decide who gets to use it. Plus HyperFlex walks into the lion's den, and every AOFAS 2026 industry lab in one place.

• Treace and Paragon 28 by the Numbers, Plus Lapidus Launches

  FY2023 results for the two public pure-plays, and a newcomer in biologics.

• No Summer Break: Paragon 28, Enovis, Ossio, and Vilex Launch

  Four launches heading into AOFAS, plus a read on the May 510(k) clearances.

• ConMed Acquires In2Bones — Who's Next to Go?

  The details of the deal, plus Q1 earnings from Treace and Paragon 28.

• Breaking: Arthrex's New MIS Release

  The first time FAN broke product news instead of reporting someone else's.

• Grading the December Product Launches

  Technology, company impact, and market fit — grading the launches that missed awards season.

• Golden Demobone Awards: Rotational Bunion and MIS Products of the Year

  The two hottest markets in foot and ankle go head to head for hardware of the year.

• Golden Demobone Awards: Acquisition of the Year

  The votes are in on the year's biggest deal, and two new categories open.

• Introducing the Golden Demobone Awards

  FAN's first annual awards for the products, people, and deals that defined the year.

• Total Ankle Shake-Up: The STAR Lands at DJO

  Regulators force a divestiture, Vilex takes Hintegra, and APEX 3D clears the FDA.

• Surgical Volumes Rebound, and a New Total Ankle Enters the Field

  Case volumes recover faster than forecast, plus a CE mark and a new total ankle.

• Michael Jordan's Navicular and the Future of Med Ed

  Stress fractures, The Last Dance, and where medical education goes after COVID.

• MIS Bunion Systems Compared: Arthrex, Novastep, and Wright Medical

  A side-by-side look at the three MIS bunion platforms currently on the market.